Daiichi Sankyo Co Ltd ASCO 2022 Highlights Transcript
[Interpreted] Thank you very much for waiting. Now we'd like to start Daiichi Sankyo's ASCO highlights. I'm Astakura from Corporate Communications Department, and I will serve as MC today.
First, let me explain the language for this meeting. We are going to use Japanese and English in this web conference. Simultaneous interpretation is available. Please click interpretation icon at the bottom of the Zoom screen and select the language from Japanese, English or off. If you select off, you will hear the original sound. English presentation materials will be displayed on the Zoom screen. Presentation materials in Japanese and English are posted on our corporate website under the IR Materials section in the IR library. You can download the file for your reference, if you want.
Today, 3 members are participating as shown on Page 3. President and CEO, Sunao Manabe; Head of Global R&D, Ken Takeshita; and Head of Global Oncology Clinical Development, Gilles Gallant. You can find the agenda for today on Page 4. First, Ken Takeshita will make an introduction, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
